People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Personalis, Inc. | — | Biotechnology | Series B | $68.9M | $485.2M | 2017 |
| Velomedix, Inc. | — | Biotechnology | Series A | $27.3M | $335.9M | 2009 |
| AtheroMed Inc | — | Other Health Care | Series A | $24.7M | $87.7M | 2009 |
Ken Ludlum at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ken Ludlum on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Casey Tansey | 1 | 14 |
| Daniel Burnett | 1 | 11 |
| Casper De Clercq | 1 | 9 |
| Jonathan MacQuitty | 1 | 7 |
| Tony Chou | 1 | 7 |
| Chris Schaepe | 1 | 6 |
| J. Casey McGlynn | 1 | 5 |
| John Dean | 1 | 5 |
| JON FEIBER | 1 | 5 |
| Andrew Cleeland | 1 | 5 |
| David Schulte | 1 | 4 |
| Andrew Chung | 1 | 4 |
| Patrick Balthrop | 1 | 3 |
| Casey McGlynn | 1 | 3 |
| Jim Dennis | 1 | 2 |
| John West | 1 | 2 |
| Sue Siegel | 1 | 2 |
| Marc Galletti | 1 | 2 |
| Will McGuire | 1 | 2 |
| Vincent Miles | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.